Skip to main content

Table 1 Baseline Characteristics (59 patients)

From: Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)

Sex (f/m)

 

58/1

Mean age (y, range)

57.4 (32 - 80)

Age ≤ 60y

 

63 % (n = 37)

Hormone receptor positive

83 % (n = 49)

Her2 neu positive (triple)

34 % (n = 20)

Grading (1/2/3/ not available)

7 % (n = 4)/ 44 % (n = 26)/36 % (n = 21)/13 % (n = 8)

Median time from first BC diagnosis to diagnosis of liver metastases (mo, range)

45 (0 – 335.4)

Median time from diagnosis of liver metastases to first interventional treatment (mo, range)

22 (1 - 294)

Mean number of liver metastases (n, range)

13 (1 - 88)

Mean maximum diameter of liver metastases (cm, range)

4.9 (1 - 14)

Mean liver volume (mL, range)

1445 (801 - 2202)

Mean volume of liver metastases (mL, range)

129.6 (0.5 - 976)

Mean tumor load (%, range)

8.2 (0.1 - 51.4)

Extrahepatic metastases

49 % (n = 29)

 

Bone only

n = 19

 

Bone

n = 24

 

Lung

n = 6

 

Lymphatic nodes (others than axillary)

n = 4

 

Peritoneum

n = 1